U.S. patent application number 10/839874 was filed with the patent office on 2004-10-14 for single-use syringe.
This patent application is currently assigned to AFRA DESIGN PTY. LIMITED.. Invention is credited to Popovsky, Frank.
Application Number | 20040204678 10/839874 |
Document ID | / |
Family ID | 25646247 |
Filed Date | 2004-10-14 |
United States Patent
Application |
20040204678 |
Kind Code |
A1 |
Popovsky, Frank |
October 14, 2004 |
Single-use syringe
Abstract
A single use syringe (10) includes a needle (18), barrel (16),
plunger assembly (20) and shield (12). The barrel (16) bears a
locking member (26) which encircles the front end of the barrel
(16) and is carried forward by the barrel (16) to a position where
it engages the shield (12) and is retained by the shield (12) such
that the locking member (26) is separated from the barrel (16) as
the barrel (16) is withdrawn rearwardly after use. The locking
member (26) is resilient and, after it is removed from the barrel
(16), assumes a configuration which prevents subsequent forward
movement of the barrel (16) within the shield (12). The barrel
includes a frangible seal (30) which is broken by rearward movement
of needle mount (32). The shield (12) includes a shield extender
(14) for controlling the depth of penetration of the needle. The
syringe can also be used to inject medicament into a IV bag via a
male port as shown in FIG. 7.
Inventors: |
Popovsky, Frank; (Tahmoor,
AT) |
Correspondence
Address: |
SCHWEGMAN, LUNDBERG, WOESSNER & KLUTH, P.A.
P.O. BOX 2938
MINNEAPOLIS
MN
55402
US
|
Assignee: |
AFRA DESIGN PTY. LIMITED.
|
Family ID: |
25646247 |
Appl. No.: |
10/839874 |
Filed: |
May 6, 2004 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
10839874 |
May 6, 2004 |
|
|
|
10206868 |
Jul 26, 2002 |
|
|
|
10206868 |
Jul 26, 2002 |
|
|
|
PCT/AU00/01027 |
Aug 30, 2000 |
|
|
|
Current U.S.
Class: |
604/110 |
Current CPC
Class: |
A61M 5/46 20130101; A61M
5/326 20130101; A61M 2005/3104 20130101; Y10S 128/919 20130101;
A61M 5/3204 20130101; A61M 5/3202 20130101; A61M 2005/3267
20130101; A61M 2005/3247 20130101; A61M 2039/042 20130101; A61M
5/288 20130101 |
Class at
Publication: |
604/110 |
International
Class: |
A61M 005/00 |
Foreign Application Data
Date |
Code |
Application Number |
Aug 2, 2001 |
WO |
01/54758 A1 |
Jan 27, 2000 |
AU |
PQ 5249 |
Jul 3, 2000 |
AU |
PQ 8484 |
Claims
What is claimed is:
1. A single-use syringe, comprising: a shield; a barrel adapted to
contain a medicament and mounted for axial reciprocation within the
shield; and a locking member initially mounted on the barrel,
wherein the locking member engages the shield during expression of
medicament from the barrel, and subsequent to said engagement is
dismounted from the barrel, the dismounted locking member
thereafter preventing reciprocation of the barrel within the
shield.
2. A single-use syringe as claimed in claim 1, wherein the locking
member initially encircles a forward end of the barrel, and is
dismounted from the forward end of the barrel during rearward
reciprocation of the barrel within the shield.
3. A single-use syringe as claimed in claim 1, wherein the shield
includes a slot, and wherein the locking member engages, and is
retained by, the slot.
4. A single-use syringe, comprising: a shield; a barrel adapted to
contain medicament and mounted for axial reciprocation within the
shield; and a locking member initially mounted relative to the
barrel for reciprocation therewith, wherein the locking member
engages and is retained by the shield during expression of
medicament from the barrel, and as a result of said engagement and
retention the locking member is translated relative to the barrel
during rearward reciprocation of the barrel within the shield, the
locking member then preventing subsequent reciprocation of the
barrel within the shield.
5. A single-use syringe comprising: a shield with a forward end and
a rearward end; a barrel with a forward end and a rearward end, the
barrel mounted for axial reciprocation within the shield between a
rearward position and a forward position; a needle mounted on the
forward end of the barrel such that when the barrel is in the
forward position the needle is exposed; a locking member adapted to
prevent exposure of the needle by forward reciprocation of the
barrel when the locking member is dismounted from the barrel, the
locking member being removably mounted to the forward end of the
barrel and adapted to engage the forward end of the shield when the
needle is exposed by forward reciprocation of the barrel, the
engagement being sufficient to dismount the locking member from the
forward end of the barrel during rearward reciprocation of the
barrel, the locking member thereafter preventing further exposure
of the needle by forward reciprocation of the barrel.
Description
RELATED APPLICATIONS
[0001] This application is a continuation of U.S. patent
application Ser. No.: 10/206,868, filed Jul. 26, 2002, which is a
continuation under 35 U.S.C. 1.111 (a) of International Application
No. PCT/AU00/01027 filed Aug. 30, 2000 and published in English as
WO 01/54758 A1 on Aug. 2, 2001, which claimed priority from
Australian Applications PQ 5249 filed Jan. 27, 2000, and PQ 8484
filed Jul. 3, 2000, which applications and publication are
incorporated herein by reference.
FIELD OF INVENTION
[0002] The present invention relates to single-use syringes.
BACKGROUND OF THE INVENTION
[0003] In recent times there has been a proliferation of single-use
syringe designs which incorporate shields that can be moved to a
forward position to shield the needle after use. In most instances,
the shield is locked in the forward position after use to prevent
multiple uses of the syringe and/or to prevent inadvertent
needle-stick injury.
[0004] Examples of syringe designs incorporating shields can be
found in U.S. Pat. No. 5,584,818 to Morrison, U.S. Pat. No.
5,492,536 to Mascia, U.S. Pat. No. 5,527,294 to Weatherford, U.S.
Pat. No. 5,591,138 to Vaillancourt, U.S. Pat. No. 6,099,504 to
Gross, U.S. Pat. No. 4,820,275 to Haber, U.S. Pat. No. 5,269,761 to
Stehrenberger, U.S. Pat. No. 5,562,626 to Sanpietro, U.S. Pat. No.
4,863,434 to Bayless, U.S. Pat. No. 4,985,021 to Straw, U.S. Pat.
No. 5,057,079 to Tiemann, U.S. Pat. No. 5,057,086 to Dillard, U.S.
Pat. No. 5,092,851 to Ragner, U.S. Pat. No. 5,201,720 to Borgia,
U.S. Pat. No. 5,215,534 to De Harde, U.S. Pat. No. 5,215,535 to
Gettig, U.S. Pat. No. 5,222,945 to Basnight, U.S. Pat. No.
5,290,256 to Weatherford, U.S. Pat. No. 5,312,372 to De Harde, and
U.S. Pat. No. 5,360,408 to Vaillancourt.
[0005] Most of these shielded-syringe designs are provided to the
user with the shield in the retracted position and thus some
triggering or manual manipulation of the shield is required to
release the shield to the forward position after use. In many
designs, the movement of the shield to the forward position after
use is assisted by a spring.
[0006] Only a few of these known designs are provided to the user
with the shield initially in the forward position. In these cases,
it is necessary for the user to manipulate some form of release
mechanism to enable the shield to be moved to the rearward position
to expose the needle for use, and after use it is again necessary
to manipulate some form of release mechanism to release the shield
to the forward position. Again, many of these designs incorporate a
spring which biases the shield to the forward position.
SUMMARY OF INVENTION
[0007] According to one aspect the invention resides in a
single-use syringe which is provided to the user with the shield in
a forward position, yet requires no manual manipulation of release
mechanisms or the like to release the shield to the rearward
position for use, nor further manual manipulation to release and
lock the shield in the forward position after use.
[0008] The above ergonomic advantages are achieved by a single-use
syringe as defined in the attached claims.
BRIEF DESCRIPTION OF THE DRAWINGS
[0009] The invention will now be described with reference to an
example for illustrative purposes and wherein:--
[0010] FIGS. 1 to 6 are a series of sequential longitudinal
sectioned views of a single-use syringe demonstrating operation of
the single-use syringe; and
[0011] FIG. 7 shows the single-use syringe engaging the male port
of an IV fluid bag.
DETAILED DESCRIPTION
[0012] Referring firstly to FIG. 1, there is illustrated a
pre-filled single-use syringe 10 including a shield 12 having a
shield extender 14, a barrel 16 mounted for reciprocation within
the shield 12 and having a needle 18 at its forward end, and a
plunger assembly 20 mounted for reciprocation within the barrel
16.
[0013] The shield 12 is generally cylindrical in shape and includes
a generally cylindrical shield extender 14 at its forward end. The
shield extender 14 can be selectively extended to control the depth
of penetration of the needle during use as will be described in
more detail later. Conventional finger receiving portions 22 are
defined towards the rear end of the shield 12, the finger receiving
portions 22 adapted to receive a user's fingers in the conventional
manner during use. The forward end of the shield includes a
circular slot 24 which engages a retains a locking member 26 during
use as will be described later. The rearward end of the shield
includes a rear collar flange 28 which limits the barrel's 16
rearward travel within the shield 12.
[0014] The barrel 16 is pre-filled with medicament and is sealed at
its rearward end by the plunger assembly 20 and at the forward end
by a frangible seal 30 which can be broken by the needle mount 32
prior to use as will be discussed later. The needle 18 extends
forwardly from the needle mount 32 which is itself located
immediately forward of the frangible seal 30. The barrel 16 bears a
generally cylindrical bifurcated locking member 26 about its
forward end which is adapted to engage and be retained by the
circular slot 24 in the shield 12 as will be described in greater
detail later.
[0015] The plunger assembly 20 is conventional in construction and
includes a piston 34 at its forward end which sealingly engages the
internal bore of the barrel 16.
[0016] The plunger assembly 20 also defines a conventional thumb
engaging portion 36 at its rearward end.
[0017] Referring firstly to FIG. 1 there is illustrated a
pre-filled single-use syringe in the form in which it would be
supplied to a user. Normally, the pre-filled single-use syringe 10
would be individually packaged and supplied in a sterile plastic
package which is not illustrated. Both the packaging and syringe
itself would identify the medicament and volume of medicament
present in the barrel of the syringe.
[0018] As mentioned above, the medicament is sealed within the
barrel 16 by the piston 34 of the plunger assembly 20 at the
rearward end of the barrel 16 and by a frangible seal 30 at the
forward end of the barrel 16.
[0019] The first step in the use of the syringe is the breaking of
the frangible seal 30 and this is best understood with comparative
reference to FIGS. 1 and 2.
[0020] Shield extender 14 is mounted via a coarse screw thread on
the forward end of shield 12 such that rotation of shield extender
14 relative to shield 12 causes the shield extender to reciprocate
in the forward or aft direction relative to shield 12.
[0021] As can be seen with reference to FIG. 1, the syringe is
provided with the shield extender 14 in a slightly forward
position, i.e. the shield extender 14 extends slightly forward
beyond the forward-most extent of the shield 12.
[0022] A cap 38 is provided, and the cap 38 has an outer skirt
which is frictionally seated on the shield extender 14 as shown.
The shield extender 14 also has a small outwardly extending
shoulder which is engaged by the outer skirt and prevents rearward
movement of the cap 38 relative to the shield extender 14. The cap
38 also encloses the needle 18 with a rearwardly extending inner
skirt which seats on the tapered forward end of the needle mount 32
as shown.
[0023] With reference now to FIG. 2, the cap 38 and shield extender
14 have been rotated relative to shield 12 such that the shield
extender 14 and cap have moved in unison rearwardly relative to
shield 12 until the rear end of the shield extender 14 has abutted
a small outwardly extending shoulder formed on the shield 12 which
prevents further rearward movement of the shield extender 14
relative to the shield 12. Simultaneously, the needle mount 12 has
been driven rearwardly by the inner skirt of the cap 38 such the
frangible seal 30 has been broken and the needle 18 is thus now in
fluid communication with the interior of the barrel 16. The
frangible seal 30 is designed to have a portion of its
circumference form a "live" or integral hinge about which the
remainder of the frangible seal 30 pivots. A frangible seal and
live hinge per se is known from PCT/AU99/00422.
[0024] It will be noted that the needle mount 32 is
non-conventional in construction in that it is cylindrical and
fully contained within the seal-containing bore of the
spigot-shaped nose of the barrel 16. In contrast, conventional
needle mounts include a rearwardly projecting skirt which surrounds
the exterior of the spigot-shaped nose of the barrel 16. It is for
this reason that the syringe disclosed in PCT/AU99/00422 utilised a
cylindrical tube 21 intermediate the conventional needle mount 7
and frangible seal 9 for the purpose of breaking the frangible seal
9.
[0025] With reference to FIG. 3, cap 38 has been removed and the
needle is now ready for use with the needle being shielded, but in
fluid communication with the interior of the barrel 16 which
accommodates the medicament.
[0026] Referring to FIG. 3A, the shield extender 14 has been
rotated in the reverse direction relative to the shield 12 such
that the shield extender 14 has moved forwardly relative to shield
12 from its fully retracted position and it now extends forwardly
beyond the forward-most extent of shield 12. Selective rotation of
shield extender 14 relative to shield 12 allows the user to control
the depth of penetration of the needle 18 during use. The further
the shield extender 14 is extended beyond the shield 12, the
shallower the penetration of the needle 18 in the patient.
[0027] With reference now to FIG. 4, the user has begun squeezing
together thumb receiving portion 36 of the plunger assembly 20 and
finger-receiving portions 22 of the shield 12 in the conventional
manner thereby compressing compression spring 40 which is provided
between a small outwardly extending shoulder formed on the rear end
of barrel 16 and a small inwardly directed shoulder formed midway
along the length of shield 12.
[0028] As shown in FIG. 4, the plunger assembly 20 has not yet
moved forwardly relative to barrel 16 to express medicament from
the needle 18. Rather, plunger assembly 20 and barrel 16 have moved
forwardly in unison within shield 12 and shield extender 14.
Plunger assembly 20 and barrel 16 will continue to move forward in
unison until the forward end of barrel 16 engages the forward end
of shield 12 whereat the compression spring 40 reaches its maximum
compression.
[0029] With reference now to FIG. 5, the barrel 16 has moved to the
fully forward position relative to shield 12 such that the forward
end of barrel 16 engages the forward end of shield 12 and the
needle 18 is maximally exposed. Thereafter, any further squeezing
together of the thumb receiving portion 36 and finger receiving
portions 22 in the conventional manner causes the plunger assembly
20 to move forward relative to barrel 16 thereby expressing the
medicament from the interior of the barrel 16.
[0030] With reference to FIG. 5, it should be noted that the
forward end of locking member 26 (which has been carried forward on
the forward end of barrel 16) has engaged the circular slot 24
defined in the forward end of shield 12. The locking member 26 is
thereafter retained in this position by virtue of its engagement
with the slot 24.
[0031] With reference to FIG. 6, the squeezing force applied by the
user has been discontinued and the barrel 16 and plunger assembly
20 have moved rearwardly in unison under the influence of
compression spring 20. It will be noted that locking member 26 is
retained in the circular slot 24 defined in the forward end of
shield 12. As barrel 16 moves rearwardly relative to shield 12,
locking member 26 slides or is pulled off the forward end of barrel
16 until it is fully clear of barrel 16 as shown in FIG. 6. At this
stage, the rear end of locking member 26, which is formed of a
resilient plastics material having a memory, snaps inwardly to
adopt a truncated and bifurcated cone-like shape as shown in FIG.
6. Of course, previously whilst the locking member 26 was
encircling barrel 16, it adopted a bifurcated cylindrical shape.
Thus, the resilient memory of the locking member 26 causes the
locking member to change shape from a generally cylindrical shape
to a generally truncated cone-like shape when it is "pulled" off
the forward end of the barrel 16 via its engagement with slot
24.
[0032] Once the locking member 26 has adopted the truncated
cone-like shape as shown in FIG. 6, subsequent forward movement of
the barrel 16 relative to the shield 12 is prevented by virtue of
physical interference with the locking member 26 and hence the
locking member 26 prevents subsequent unshielding of the needle
18.
[0033] Referring to FIG. 7, the single-use syringe can also be
conveniently used in a safe manner with intravenous polybags as
shown. In this regard, the forward end of the shield 12 is sized so
as to closely receive the male port of a polybag as shown.
Typically, these male ports are sealed by a rubber plug as shown.
The needle can penetrate through the rubber plug and the medicament
can then be injected into the polybag for IV feed to the patient
via an established catheter or the like. After injection of the
medicament into the polybag, the needle is withdrawn and the rubber
plug is sufficiently resilient to be reseal the male port of the
poly bag.
[0034] The present invention provides a single-use syringe which is
supplied to the user with the shield in the forward or shielding
position, yet requires no non-conventional manipulation or
activation of release mechanisms or the like to move the shield
back to the needle-exposed position for use. Furthermore, no
non-conventional manipulation of release mechanisms or the like is
required to release the shield to the forward protective position
after use. The user simply squeezes their thumb and fingers
together in the conventional manner and this single, conventional
action exposes the needle 18, activates the locking member 26 via
its engagement with the slot 24, and expresses the medicament.
Discontinuation of the squeezing force cause the shield to return
to its forward or protective position under spring bias whereat it
is locked to prevent subsequent use or inadvertent needle-stick
injuries.
[0035] It will of course be realised that whilst the above has been
given by way of an illustrative example of this invention, all such
and other modifications and variations hereto, as would be apparent
to persons skilled in the art, are deemed to fall within the broad
scope and ambit of this invention as is herein set forth.
* * * * *